Project Number 5U01AG061359-05 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for Metabolomic Signatures for Disease Sub-classification and Target Prioritization in AMP-AD Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 2. Identification and Validation of Novel Targets Researcher and Organization Principal Investigator KADDURAH-DAOUK, RIMA F Principal Investigator First Name RIMA Principal Investigator Last Name KADDURAH-DAOUK Awardee Organization DUKE UNIVERSITY Awardee State North Carolina Contact PI Country United States Project Detail Funding Opportunity Announcement RFA-AG-18-013: Continuation of the AMP-AD Target Discovery and Preclinical Validation Consortium (U01 Clinical Trial Optional) FY Overall Cost $1,928,443 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official PETANCESKA, SUZANA Special Initiative Accelerating Medicines Partnership - Alzheimer's Disease (AMP-AD): Target Discovery and Preclinical Validation Project
